Omicron-specific vaccine boosters get FDA sign-off
Coronavirus,FDA,Coronavirus Vaccine,Booster Shots,CDC,Pfizer,Moderna,BioNTech,BA.5 Variant,Omicron Variant
COVID-19 vaccines designed to target the omicron variant have just been authorized by the Food and Drug Administration. Both Pfizer / BioNTech and Moderna got the FDA’s sign-off for their booster doses of the reformulated shot. This is the first update to COVID-19 vaccines to be authorized in the United States.
The Pfizer / BioNTech booster is available to people 12 and older, and the Moderna shot will be available to people 18 and older. They’ll only be boosters — they can’t be used by people who haven’t already had their first doses.
Related Coverage
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
Commentators From Left and Right Preemptively Blame 'Other Side' for Lawfare
November 16th, 2026
Headline Roundup
Could There Be More Behind Jensen Huang's Resignation Than Extramarital Affairs?
November 15th, 2026
Recommended Reading
When Democrats Have To Decide
Dan Schnur
November 16th, 2026